FERRETTI, VIRGINIA VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 683
EU - Europa 510
AS - Asia 247
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.445
Nazione #
US - Stati Uniti d'America 678
CN - Cina 241
IE - Irlanda 218
IT - Italia 89
FI - Finlandia 67
DE - Germania 45
SE - Svezia 36
UA - Ucraina 36
GB - Regno Unito 7
CA - Canada 5
AT - Austria 4
FR - Francia 3
IN - India 3
AU - Australia 2
BE - Belgio 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
EG - Egitto 1
IR - Iran 1
JP - Giappone 1
MU - Mauritius 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.445
Città #
Dublin 213
Chandler 186
Ashburn 64
Nanjing 58
Jacksonville 47
Helsinki 45
Beijing 36
New York 32
Lawrence 30
Princeton 30
Nanchang 29
Medford 27
Shanghai 27
Wilmington 23
Seattle 19
Pavia 18
Shenyang 17
Tianjin 15
Jiaxing 13
Ann Arbor 12
Changsha 12
Hebei 12
Milan 12
Hangzhou 7
Houston 6
Boardman 5
Gallarate 4
Norwalk 4
Rome 4
Washington 4
Woodbridge 4
Cork 3
Fonte Nuova 3
Los Angeles 3
Reggio Emilia 3
Toronto 3
Zhengzhou 3
Albano Sant'Alessandro 2
Berlin 2
Brescia 2
Brossard 2
Brussels 2
Casatenovo 2
Cesate 2
Des Moines 2
Domodossola 2
Falkenstein 2
Monza 2
Mumbai 2
Ospitaletto 2
Paratico 2
Redwood City 2
Sesto San Giovanni 2
Vienna 2
Bareggio 1
Bratislava 1
Cairo 1
Dhaka 1
Fairfield 1
Hanover 1
Jinan 1
Kunming 1
Leawood 1
Lincoln 1
London 1
Mariano Comense 1
Melbourne 1
Mulazzano 1
Ningbo 1
Novokuznetsk 1
Piscataway 1
Pune 1
Shijiazhuang 1
St Petersburg 1
Tokyo 1
Trecasali 1
Varese 1
Wuhan 1
Totale 1.091
Nome #
C'è una differenza nelle caratteristiche di pazienti con disturbo borderline della pesonalità con e senza attacchi di panico? Evidenze da uno studio osservazionale longitudinale. 77
Epidemiology of multiple sclerosis in south-western Sardinia 69
Brain aging and dementia during the transition from late adulthood to old age: design and methodology of the “Invece.Ab” population-based study 67
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 64
Salute, qualità ambientale e stili di vita II 62
Clinical significance of somatic mutation in unexplained blood cytopenia 59
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation. 58
Non expanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. 56
Stress lavoro-correlato nell'Azienda Ospedaliera della Provincia di Pavia:quale il grado di diffusione e la tipologia? 51
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin 51
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 48
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 45
Uso dei mezzi di trasporto in ambiente urbano. Cosa è cambiato rispetto all’indagine del 2003? 44
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 44
An mHealth app counseling patients and general practitioners about Multiple Myeloma 44
Influence of socio-demographic features and ApoE-epsilon 4 expression on the prevalence of dementia and cognitive impairment in a population of 70-74 year olds: the InveCe.Ab study 44
Epidemiology and geographical variation of myastheniagravis in the province of Pavia, Italy 44
‘Real-life’ study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis 43
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice 37
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas 35
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 35
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 33
ICA-EMA: A Tool for Assessing Nursing Complexity of Patients With Oncohematologic Disease in an Italian Center 33
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 33
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network 32
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders 31
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO 31
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: Results from a large cohort of patients 27
Circulating endothelial cells in COVID-19 25
Leptin Levels of the Perinatal Period Shape Offspring’s Weight Trajectories through the First Year of Age 23
Men with COVID-19 die. Women survive 22
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis 21
Relationship between clone metrics and clinical outcome in clonal cytopenia 20
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 19
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 18
More on age and gender in COVID-19 17
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 17
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 13
The economic burden of multiple myeloma. Definition of a model for forecasting patients’ costs 12
Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19 9
null 4
Assessment of different manufacturing techniques for the production of bioartificial scaffolds as soft organ transplant substitutes 2
Totale 1.519
Categoria #
all - tutte 6.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020228 67 100 0 7 0 7 3 7 3 14 18 2
2020/2021129 16 4 3 9 0 29 2 14 22 10 14 6
2021/2022145 0 2 2 4 7 5 1 8 8 9 21 78
2022/2023572 49 55 3 32 41 44 1 32 246 2 47 20
2023/2024330 42 70 15 27 24 80 16 37 8 7 4 0
Totale 1.519